CT-Luso is now recognised for its contribution to the development of clinical research and clinical trials across Portuguese-speaking countries. The testimonials were collected by the CT-Luso team from the project’s partners.
In Angola, the Agency for the Regulation of Medicines and Health Technologies (ARMED) highlights CT-Luso’s impact on the development and consolidation of the national regulatory framework for clinical trials and biomedical research, including the approval of Law No. 7/25 of 24 July. The National Centre for Scientific Research (CNIC) also highlights the project’s contribution to strengthening institutional and technical capacities in clinical research and health ethics.
In Cabo Verde, the National Committee for Ethics in Health Research (CNEPS) highlights CT-Luso’s influence on the institutions directly benefiting from the project, as well as its contribution to raising awareness among national authorities of the importance of ethics in scientific research. The Independent Health Regulatory Authority (ERIS) stresses the project’s strategic relevance to capacity building in clinical trials, while the National Institute of Public Health (INSP) identifies it as an opportunity to strengthen national technical and scientific capacity.
In Guinea-Bissau, the Bandim Health Project (BHP) highlights CT-Luso’s strategic role in strengthening clinical research capacity, developing human resources and improving research practices. The National Committee for Ethics in Health Research (CNEPS) and the Regulatory Authority for Pharmacy, Laboratory and Medicines (ARFAME) identify local capacity building, legislative harmonisation and the creation of partnerships as important elements for the sustainability of clinical trials and biomedical research.
In Mozambique, the National Bioethics Committee for Health (CNBS) highlights CT-Luso’s contribution to strengthening the capacities of ethics committees and researchers through training, the development of regulatory instruments and the sharing of good practices. The National Health Institute (INS) also plans to integrate and adapt project tools for the implementation of clinical trials, in coordination with CNBS, the National Regulatory Authority for Medicines (ANARME), and the Faculty of Medicine of Eduardo Mondlane University (FAMED-UEM).
In São Tomé and Príncipe, CT-Luso has been supporting initiatives aimed at developing the ethical, regulatory and institutional foundations for clinical research, including capacity building for the Ethics Committee for Health and Scientific Research (CESIC). The project also supports the strengthening of expertise in regulation, pharmacovigilance and clinical trials, in coordination with the Pharmaceutical Department of the Ministry of Health. Also noteworthy is the CT-Luso partnership with the Victor Sá Machado Higher Institute of Health Sciences at the University of São Tomé and Príncipe in the preparation of the new Master’s Degree in Global Bioethics and Ethical Health Management.
